Single subject — no qualification is awarded on completion. Credits toward the qualifications listed below.
This subject is FEE-HELP eligible, so eligible students can defer the $2,862 fee as a government loan and pay nothing upfront.
Fees and funding are indicative only. Confirm your eligibility and final costs with the provider.
A student visa requires a full-time CRICOS-registered course, and single subjects have no CRICOS registration. If you’re studying in Australia on a student visa, you’ll need a full qualification instead.
See CRICOS-registered alternativesTAS-CSA725 is a self-directed, fully online subject, that explores a variety of disease states and their management, using a series of patient cases linked to assignment-based questions, to enable you to enhance your knowledge in the area of clinical pharmacy and pharmaceutical care. This subject covers the medication management and clinical pharmacy issues in endocrinology, rheumatology and oncology supportive care.
Advanced Pharmacotherapeutics in Endocrinology, Rheumatology and Oncology Care is a standalone subject at University of Tasmania in TAS. Completing it does not award a qualification. Credit may apply toward the qualifications listed on this page.
No qualification credit mapping has been indexed for this subject yet. The provider may still grant credit toward a related award — confirm with University of Tasmania before enrolling.
University of Tasmania is the awarding provider. Recorded study modes are Online. Typical duration is listed as 12 weeks. The subject is listed at 25 credit points. Eligible students may defer fees through FEE-HELP.
Details on this page are compiled from the provider's published subject information and government registers. Fees, intakes and credit rules can change — confirm current details with University of Tasmania before enrolling.
Prior study required
